Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Oktober 2024 04:00 ET | Quelle: Laverock Therapeutics

Laverock Therapeutics to Present New Data on Programmable, Tunable, Stable and Specific Gene Silencing Platform at ESGCT

STEVENAGE, United Kingdom, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
26. September 2024 04:00 ET | Quelle: Laverock Therapeutics

Laverock Therapeutics makes significant advances in its unique programmable gene silencing platform and announces pipeline focus on advanced therapies in oncology and genetic diseases

Programmable, tunable, stable and specific gene silencing has been demonstrated across multiple target genes and multiple cell typesPoC achieved with concomitant silencing of more than one...
05. September 2024 04:00 ET | Quelle: Laverock Therapeutics

Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule

STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
26. März 2024 05:00 ET | Quelle: Laverock Therapeutics

Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team

STEVENAGE, United Kingdom, March 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...